Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale

Brief Summary

Official Title: “Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale”

The objective of the present study is to evaluate the effectiveness of postnatal depression screening by comparing the mental health outcome (at 6 months postpartum) of mothers under the Edinburgh Postnatal Depression Scale (EPDS) screening programme versus usual clinical practice (usual practice), using randomized controlled trial design. With the use of the EPDS for the screening of postnatal depression, it is expected that more mothers in need of intervention (including mental health intervention, guidance in childcare and parenting, counseling in family relationships, etc) will be picked up and offered appropriate intervention, compared to the usual practice. It is hypothesized that the mental health of the group of women under the EPDS screening programme will be better than those under the usual practice, on subsequent follow-up.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Diagnostic

Interventions Used in this Clinical Trial

  • Procedure: Edinburgh Postnatal Depression Scale

Outcome Measures for this Clinical Trial

Primary Measures

  • Mother’s mental health at 6 months postpartum, as measured on the EPDS and General Health Questionnaire-12 (GHQ-12), both being self-report questionnaires.

Secondary Measures

  • Mother’s parenting stress (measured by the Parenting Stress Index, a self-report questionnaire)
  • Marital relationship satisfaction (measured by the Chinese Kansas Marital Satisfaction Scale, a self-report questionnaire)
  • Marital status and employment status (both father and mother, where applicable) at 6 and 18 months postpartum
  • Child health measures, including weight at 6 and 18 months, number of hospitalizations and visits to doctors within the first 6 and 18 months as reported by mother
  • Mother’s mental health outcome (EPDS and GHQ scores) at 18 months postpartum

Criteria for Participation in this Clinical Trial

Inclusion Criteria

1. Chinese mothers of newborn babies <= 2 months who are registered with the 4 Maternal and Child Health Centres under study;

2. Normally resident in Hong Kong (Hong Kong ID card holder, or HK Birth Certificate [with status of permanent resident indicated established] holder, or people who have been granted unconditional stay in Hong Kong, or passport holders having valid travel document showing the right to land in Hong Kong, or permission to land, or eligibility of HK permanent ID card verified, or entitlement to the right of abode in HK)

Exclusion Criteria

1. Those who do not use the Chinese language (in both the written and spoken form);

2. Those who are under active psychiatric contact;

3. Those who delivered in hospitals which are still conducting their own EPDS screening programme.

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: N/A

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial: Accepts Healthy Volunteers

Clinical Trial Investigator Information

  • Lead Sponsor
    • Chinese University of Hong Kong
  • Collaborator
    • Hong Kong Department of Health
  • Overall Official(s)
    • Dominic TS Lee, M.D., Principal Investigator, Department of Psychiatry, The Chinese University of Hong Kong
    • Shirley SL Leung, MPH, Principal Investigator, Family Health Service, Department of Health, HKSAR
  • Overall Contact(s)
    • Cynthia Leung, fhssro@dh.gov.hk

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00251342